VC Deals Analysis: Variety In Volume, But Lackluster Value In April

It would have been difficult to beat March's unusual bumper harvest, which benefitted from Grail's near-$1bn round, but venture fundraising efforts in April were stymied by the absence of deals beyond the $50m mark.

Money Energy of success

[Editors' note: For more details about VC deals in 2017 and previous years, go to Medtech Insight's VC deal tracker: https://medtech.pharmamedtechbi.com/datasets/vc-funding]

Deal volume bounced back in April after a two-month lag, with 26 transactions of $1m-and-over recorded by Medtech Insight's VC deal tracker

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Financing

More from Business